| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Nov 17, 2025 | Dec 5, 2025 | Vaxart, Inc. | Director | Buy | 90.0 | +20,000 | 19.21% | ✗ | $8.2K |
| Jul 29, 2025 | Jul 31, 2025 | Vaxart, Inc. | Director | Buy | 90.0 | +10,000 | 10.62% | ✗ | $4.1K |
| Jun 18, 2024 | Jun 20, 2024 | Vaxart, Inc. | Director | Buy | 91.3 | +20,000 | 34.41% | ✗ | $13.6K |
| Dec 28, 2022 | Dec 28, 2022 | Vaxart, Inc. | Director | Buy | 91.3 | +20,000 | 100.00% | ✗ | $15.1K |
| Dec 12, 2019 | Feb 10, 2020 | Inhibitor Therapeutics, Inc. | Director | Buy | 47.5 | +500 | 0.05% | ✗ | $31 |
| Mar 8, 2017 | Mar 10, 2017 | Inhibitor Therapeutics, Inc. | Director | Sell | 22.5 | -356,400 | -23.23% | ✗ | $121.2K |
| Sep 8, 2014 | Sep 9, 2014 | Inhibitor Therapeutics, Inc. | Director | Buy | 90.0 | +10,000 | 100.00% | ✗ | $1.3K |